Sponsor:
Vivace Therapeutics, Inc
Code:
NCT04665206
Conditions
Solid Tumor, Adult
Mesothelioma
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
VT3989
Nivolumab & Ipilimumab
Osimertinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by Vivace Therapeutics, Inc on 2025-08-11.